TY - JOUR
T1 - CONOCIMIENTOS, ACTITUDES Y PRÁCTICAS DE FARMACOVIGILANCIA EN EL CONTEXTO DE LA COVID-19 EN PROFESIONALES DE LA SALUD DEL SEGURO SOCIAL DEL PERÚ
AU - Rodríguez-Tanta, L. Yesenia
AU - Ale-Mauricio, Diego André
AU - Saromo-Meléndez, Violeta
AU - Lazarte-Ramos, Anaís
AU - Gálvez-Dávila, Elisa
AU - Pecho-Arias, Gisela
AU - Urruchi-Huertas, Jack
AU - Fernández-Rojas, Paola
AU - Delgado-Escalante, Raquel
N1 - Publisher Copyright:
© 2022, Instituto Nacional de Salud. All rights reserved.
PY - 2022
Y1 - 2022
N2 - The study aimed to evaluate a group of health professionals' knowledge, attitudes, and practices on phar-macovigilance in the context of COVID-19 in the Peruvian Social Health Insurance (EsSalud). A des-criptive secondary analysis was performed on a database that included responses from an online survey conducted by the Institutional Reference Center for Pharmacovigilance and Technovigilance of EsSalud. Of 144 participants, 66% showed a high level of knowledge and 81.2% a positive attitude; however, 71.5% had an inadequate level of pharmacovigilance practice. Although EsSalud professionals demonstrated a high level of knowledge and positive attitude to implement pharmacovigilance, this is not reflected in the practice of this activity during the SARS-CoV-2 pandemic. Strategies should be employed to integrate pharmacovigilance into healthcare activities to benefit patient safety.
AB - The study aimed to evaluate a group of health professionals' knowledge, attitudes, and practices on phar-macovigilance in the context of COVID-19 in the Peruvian Social Health Insurance (EsSalud). A des-criptive secondary analysis was performed on a database that included responses from an online survey conducted by the Institutional Reference Center for Pharmacovigilance and Technovigilance of EsSalud. Of 144 participants, 66% showed a high level of knowledge and 81.2% a positive attitude; however, 71.5% had an inadequate level of pharmacovigilance practice. Although EsSalud professionals demonstrated a high level of knowledge and positive attitude to implement pharmacovigilance, this is not reflected in the practice of this activity during the SARS-CoV-2 pandemic. Strategies should be employed to integrate pharmacovigilance into healthcare activities to benefit patient safety.
KW - COVID-19 (source: MeSH NLM)
KW - Drug Safety
KW - Health Knowledge, Attitudes, Practice
KW - Healthcare Workers
KW - Pharmacovigilance
UR - http://www.scopus.com/inward/record.url?scp=85128411955&partnerID=8YFLogxK
U2 - 10.17843/rpmesp.2022.391.10651
DO - 10.17843/rpmesp.2022.391.10651
M3 - Artículo
C2 - 35766746
AN - SCOPUS:85128411955
SN - 1726-4634
VL - 39
SP - 91
EP - 97
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 1
ER -